Stanford scientists have invented a method that can determine the gestational age of a fetus by testing the mother's urine using metabolomics profiling and machine learning.
Stanford researchers have developed a non-invasive method of assessing chromosomal composition in human embryos at the blastocyst stage, thus potentially improving chances of success following in vitro fertilization (IVF).
Stanford researchers have developed methods for genetic and epigenetic diagnosis of embryos to determine those of which are more likely to be chromosomally normal and advance in development. This assessment method allows selection of healthier embryos for implantation.
Researchers in Prof. Stephen Quake's laboratory have developed a method to measure the entire fetal genome noninvasively using materials from maternal blood.